|
HY-18954-100mg
|
MedChemexpress LLC
|
NMS-P118 [CAS 1262417-51-5]
|
|
Cancer-programmed cell death
|
|
|
HY-18954-2mg
|
MedChemexpress LLC
|
NMS-P118 [CAS 1262417-51-5]
|
|
Cancer-programmed cell death
|
|
|
HY-18954-25mg
|
MedChemexpress LLC
|
NMS-P118 [CAS 1262417-51-5]
|
|
Cancer-programmed cell death
|
|
|
HY-18954-5mg
|
MedChemexpress LLC
|
NMS-P118 [CAS 1262417-51-5]
|
|
Cancer-programmed cell death
|
|
|
HY-18954-50mg
|
MedChemexpress LLC
|
NMS-P118 [CAS 1262417-51-5]
|
|
Cancer-programmed cell death
|
|
|
HY-20019-10mg
|
MedChemexpress LLC
|
L-165041 [CAS 79558-09-1]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-20019-100mg
|
MedChemexpress LLC
|
L-165041 [CAS 79558-09-1]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-20019-5mg
|
MedChemexpress LLC
|
L-165041 [CAS 79558-09-1]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-20019-50mg
|
MedChemexpress LLC
|
L-165041 [CAS 79558-09-1]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-50936-1mg
|
MedChemexpress LLC
|
Trabectedin [CAS 114899-77-3]
|
|
Cancer-programmed cell death
|
|
|
HY-50936-10mg
|
MedChemexpress LLC
|
Trabectedin [CAS 114899-77-3]
|
|
Cancer-programmed cell death
|
|
|
HY-50936-25mg
|
MedChemexpress LLC
|
Trabectedin [CAS 114899-77-3]
|
|
Cancer-programmed cell death
|
|
|
HY-50936-5mg
|
MedChemexpress LLC
|
Trabectedin [CAS 114899-77-3]
|
|
Cancer-programmed cell death
|
|
|
HY-A0004-1g
|
MedChemexpress LLC
|
Decitabine [CAS 2353-33-5]
|
|
Cancer-programmed cell death
|
|
|
HY-A0004-100mg
|
MedChemexpress LLC
|
Decitabine [CAS 2353-33-5]
|
|
Cancer-programmed cell death
|
|
|
HY-A0004-2g
|
MedChemexpress LLC
|
Decitabine [CAS 2353-33-5]
|
|
Cancer-programmed cell death
|
|
|
HY-A0004-500mg
|
MedChemexpress LLC
|
Decitabine [CAS 2353-33-5]
|
|
Cancer-programmed cell death
|
|
